K. V. Chinnampalli, “FROM RISK TO QUALITY: QUALITY RISK MANAGEMENT IN PHARMA TARGETING CANCER THROUGH IMMUNE MODULATION ”, Biospecia, vol. 2, no. 2, pp. 13–17, May 2026.